| Recurrence of FSGS after kidney transplantation in adults A Uffing, MJ Pérez-Sáez, M Mazzali, RC Manfro, AC Bauer, ... Clinical Journal of the American Society of Nephrology 15 (2), 247-256, 2020 | 120 | 2020 |
| Preserving the B-cell compartment favors operational tolerance in human renal transplantation HM Silva, MCS Takenaka, PMM Moraes-Vieira, SM Monteiro, ... Molecular medicine 18, 733-743, 2012 | 115 | 2012 |
| Validation of plasma clearance of 51Cr‐EDTA in adult renal transplant recipients: comparison with inulin renal clearance FSR Medeiros, MT Sapienza, ES Prado, F Agena, MHM Shimizu, ... Transplant International 22 (3), 323-331, 2009 | 78 | 2009 |
| The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients E David-Neto, FC Lemos, LM Fadel, F Agena, MY Sato, C Coccuza, ... Transplantation 84 (1), 50-55, 2007 | 66 | 2007 |
| GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation PMM Moraes-Vieira, MCS Takenaka, HM Silva, SM Monteiro, F Agena, ... Clinical Immunology 142 (2), 117-126, 2012 | 43 | 2012 |
| Home blood pressure (BP) monitoring in kidney transplant recipients is more adequate to monitor BP than office BP F Agena, ES Prado, PS Souza, GV Silva, FBC Lemos, D Mion Jr, ... Nephrology dialysis transplantation 26 (11), 3745-3749, 2011 | 43 | 2011 |
| Recurrence of IgA nephropathy after kidney transplantation in adults A Uffing, MJ Pérez-Saéz, T Jouve, M Bugnazet, P Malvezzi, SA Muhsin, ... Clinical Journal of the American Society of Nephrology 16 (8), 1247-1255, 2021 | 42 | 2021 |
| Aging and end stage renal disease cause a decrease in absolute circulating lymphocyte counts with a shift to a memory profile and diverge in Treg population GRR Freitas, M da Luz Fernandes, F Agena, O Jaluul, SC Silva, ... Aging and disease 10 (1), 49, 2019 | 42 | 2019 |
| A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive … E David-Neto, AHK Triboni, FJ Paula, LSV Boas, CM Machado, F Agena, ... Transplantation 98 (10), 1077-1081, 2014 | 41 | 2014 |
| Longitudinal pharmacokinetics of tacrolimus in elderly compared with younger recipients in the first 6 months after renal transplantation E David-Neto, P Romano, AHK Triboni, F Ramos, F Agena, PAR Ebner, ... Transplantation 101 (6), 1365-1372, 2017 | 31 | 2017 |
| Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: outcome and risk factors for late CMV disease JO Reusing Jr, EB Feitosa, F Agena, LC Pierrotti, LSF Azevedo, ... Transplant Infectious Disease 20 (5), e12929, 2018 | 27 | 2018 |
| Evaluation of MDRD 4, CKD‐EPI, BIS‐1, and modified Cockcroft–Gault equations to estimate glomerular filtration rate in the elderly renal‐transplanted recipients E David‐Neto, AHK Triboni, F Ramos, F Agena, NZ Galante, M Altona, ... Clinical transplantation 30 (12), 1558-1563, 2016 | 26 | 2016 |
| Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: a multicenter study TV de Sandes‐Freitas, M Mazzali, RC Manfro, LGM de Andrade, ... Transplant International 34 (6), 1093-1104, 2021 | 22 | 2021 |
| Dynamics of anti‐human leukocyte antigen antibodies after renal transplantation and their impact on graft outcome PS de Souza, E David‐Neto, N Panajotopolous, F Agena, H Rodrigues, ... Clinical transplantation 28 (11), 1234-1243, 2014 | 19 | 2014 |
| Diminished mycophenolic acid exposure caused by omeprazole may be clinically relevant in the first week posttransplantation E David-Neto, KM Takaki, F Agena, P Romano, NM Sumita, ME Mendes, ... Therapeutic drug monitoring 34 (3), 331-336, 2012 | 18 | 2012 |
| The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study E David-Neto, PS Souza, N Panajotopoulos, H Rodrigues, CG Ventura, ... Clinics 67, 355-361, 2012 | 18 | 2012 |
| Determination of viremia cut‐off for risk to develop BKP yV‐associated nephropathy among kidney transplant recipients CS Bicalho, RR Oliveira, DR David, MCDS Fink, F Agena, MC Castro, ... Transplant Infectious Disease 20 (5), e12969, 2018 | 17 | 2018 |
| Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors LS Azevedo, J Gerhard, JL Miraglia, AR Precioso, ... Transplant Infectious Disease 15 (6), 612-618, 2013 | 17 | 2013 |
| UPLC–MS/MS assay validation for tacrolimus quantitative determination in peripheral blood T CD4+ and B CD19+ lymphocytes P Romano, M da Luz Fernandes, PAR Ebner, ND de Oliveira, LM Okuda, ... Journal of Pharmaceutical and Biomedical Analysis 152, 306-314, 2018 | 16 | 2018 |
| The kinetics of anti-hla antibodies in the first year after kidney transplantation: in whom and when should they be monitored? MCR Castro, EA Barbosa, RP Souza, F Agena, PS Souza, G Maciel, ... Journal of transplantation 2018, 2018 | 13 | 2018 |
